NO20012961D0 - Trisykliske farnesylproteintransferase-inhibitorer - Google Patents
Trisykliske farnesylproteintransferase-inhibitorerInfo
- Publication number
- NO20012961D0 NO20012961D0 NO20012961A NO20012961A NO20012961D0 NO 20012961 D0 NO20012961 D0 NO 20012961D0 NO 20012961 A NO20012961 A NO 20012961A NO 20012961 A NO20012961 A NO 20012961A NO 20012961 D0 NO20012961 D0 NO 20012961D0
- Authority
- NO
- Norway
- Prior art keywords
- protein transferase
- transferase inhibitors
- farnesyl protein
- tricyclic farnesyl
- tricyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Electroluminescent Light Sources (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21639898A | 1998-12-18 | 1998-12-18 | |
| PCT/US1999/027939 WO2000037459A1 (en) | 1998-12-18 | 1999-12-16 | Tricyclic farnesyl protein transferase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20012961D0 true NO20012961D0 (no) | 2001-06-15 |
| NO20012961L NO20012961L (no) | 2001-08-16 |
Family
ID=22806914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012961A NO20012961L (no) | 1998-12-18 | 2001-06-15 | Trisykliske farnesylproteintransferase-inhibitorer |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1140902A1 (no) |
| JP (1) | JP2002533336A (no) |
| KR (1) | KR20010081116A (no) |
| CN (1) | CN1326850C (no) |
| AR (1) | AR021718A1 (no) |
| AU (1) | AU776558B2 (no) |
| BR (1) | BR9916314A (no) |
| CA (1) | CA2354779A1 (no) |
| CO (1) | CO5160350A1 (no) |
| CZ (1) | CZ20011950A3 (no) |
| HU (1) | HUP0202152A2 (no) |
| IL (1) | IL143408A0 (no) |
| NO (1) | NO20012961L (no) |
| NZ (1) | NZ511878A (no) |
| PE (1) | PE20001342A1 (no) |
| PL (1) | PL348293A1 (no) |
| SK (1) | SK7592001A3 (no) |
| TR (1) | TR200101755T2 (no) |
| WO (1) | WO2000037459A1 (no) |
| ZA (1) | ZA200104233B (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2354779A1 (en) | 1998-12-18 | 2000-06-29 | Schering Corporation | Tricyclic farnesyl protein transferase inhibitors |
| US7342016B2 (en) | 2000-08-30 | 2008-03-11 | Schering Corporation | Farnesyl protein transferase inhibitors as antitumor agents |
| AU2002236813A1 (en) * | 2001-01-22 | 2002-07-30 | Schering Corporation | Treatment of malaria with farnesyl protein transferase inhibitors |
| AU2002257114A1 (en) * | 2001-04-06 | 2002-10-21 | Schering Corporation | Treatment of malaria with farsenyl protein transferase inhibitors |
| JP2008523104A (ja) * | 2004-12-13 | 2008-07-03 | シェーリング コーポレイション | 癌を治療するための新規なファルネシルタンパク質トランスフェラーゼ阻害剤およびその使用 |
| WO2006065794A1 (en) | 2004-12-14 | 2006-06-22 | Schering Corporation | Farnesyl protein transferase inhibitors and methods for treating proliferative diseases |
| JP2009523799A (ja) * | 2006-01-19 | 2009-06-25 | シェーリング コーポレイション | ファルネシルタンパク質トランスフェラーゼインヒビターとしてのピペラジン誘導体 |
| US9914726B2 (en) | 2014-03-19 | 2018-03-13 | Vps-3, Inc. | 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ols and processes for their preparation |
| BR112016021260B1 (pt) | 2014-03-19 | 2020-05-26 | Viamet Pharmaceuticals | 2-(2,4-difluorofenil)-1,1-difluoro-1-(5-substituída-piridin-2-il)-3-(1h-tetrazol-1-il)propan-2-ois e processos para a sua preparação |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL111235A (en) * | 1993-10-15 | 2001-03-19 | Schering Plough Corp | Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them |
| US5801175A (en) | 1995-04-07 | 1998-09-01 | Schering Corporation | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| US5712280A (en) * | 1995-04-07 | 1998-01-27 | Schering Corporation | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| IL117798A (en) | 1995-04-07 | 2001-11-25 | Schering Plough Corp | Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them |
| PE92098A1 (es) * | 1996-07-31 | 1998-12-31 | Schering Corp | N-cianoiminas triciclicas utiles como inhibidores de transferasa de proteina farnesilo |
| ZA985203B (en) * | 1997-06-17 | 1999-01-05 | Schering Corp | Compounds useful for inhibition of farnesyl protein transferase |
| CA2354779A1 (en) | 1998-12-18 | 2000-06-29 | Schering Corporation | Tricyclic farnesyl protein transferase inhibitors |
-
1999
- 1999-12-16 CA CA002354779A patent/CA2354779A1/en not_active Abandoned
- 1999-12-16 SK SK759-2001A patent/SK7592001A3/sk unknown
- 1999-12-16 HU HU0202152A patent/HUP0202152A2/hu unknown
- 1999-12-16 IL IL14340899A patent/IL143408A0/xx unknown
- 1999-12-16 NZ NZ511878A patent/NZ511878A/en unknown
- 1999-12-16 BR BR9916314-4A patent/BR9916314A/pt not_active IP Right Cessation
- 1999-12-16 TR TR2001/01755T patent/TR200101755T2/xx unknown
- 1999-12-16 AU AU20307/00A patent/AU776558B2/en not_active Ceased
- 1999-12-16 EP EP99963980A patent/EP1140902A1/en not_active Withdrawn
- 1999-12-16 PL PL99348293A patent/PL348293A1/xx not_active Application Discontinuation
- 1999-12-16 KR KR1020017007632A patent/KR20010081116A/ko active IP Right Grant
- 1999-12-16 CO CO99078843A patent/CO5160350A1/es unknown
- 1999-12-16 CN CNB99816206XA patent/CN1326850C/zh not_active Expired - Fee Related
- 1999-12-16 JP JP2000589531A patent/JP2002533336A/ja active Pending
- 1999-12-16 AR ARP990106461A patent/AR021718A1/es unknown
- 1999-12-16 CZ CZ20011950A patent/CZ20011950A3/cs unknown
- 1999-12-16 WO PCT/US1999/027939 patent/WO2000037459A1/en active Application Filing
- 1999-12-17 PE PE1999001295A patent/PE20001342A1/es not_active Application Discontinuation
-
2001
- 2001-05-23 ZA ZA200104233A patent/ZA200104233B/en unknown
- 2001-06-15 NO NO20012961A patent/NO20012961L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TR200101755T2 (tr) | 2001-09-21 |
| BR9916314A (pt) | 2001-10-02 |
| HUP0202152A2 (en) | 2002-10-28 |
| ZA200104233B (en) | 2002-08-22 |
| CZ20011950A3 (cs) | 2001-12-12 |
| CO5160350A1 (es) | 2002-05-30 |
| SK7592001A3 (en) | 2002-03-05 |
| CN1334811A (zh) | 2002-02-06 |
| NZ511878A (en) | 2003-10-31 |
| EP1140902A1 (en) | 2001-10-10 |
| AU776558B2 (en) | 2004-09-16 |
| CN1326850C (zh) | 2007-07-18 |
| PE20001342A1 (es) | 2000-12-09 |
| IL143408A0 (en) | 2002-04-21 |
| KR20010081116A (ko) | 2001-08-27 |
| AU2030700A (en) | 2000-07-12 |
| NO20012961L (no) | 2001-08-16 |
| PL348293A1 (en) | 2002-05-20 |
| CA2354779A1 (en) | 2000-06-29 |
| JP2002533336A (ja) | 2002-10-08 |
| WO2000037459A1 (en) | 2000-06-29 |
| AR021718A1 (es) | 2002-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE04309B1 (et) | Farnesüül-proteiini transferaasi inhibiitorid | |
| EE9800408A (et) | Proteiinfarnesüültransferaasi inhibiitorid | |
| NO996571D0 (no) | Inhibitorer for farnesyl-protein-transferase | |
| EE9700314A (et) | Farnesüül-proteiini transferaasi inhibiitorid | |
| DE69924876D1 (de) | Farnesyl protein transferase inhibitoren | |
| FI951554A0 (fi) | Imidatsolipitoisia farnesyyliproteiinitransferaasi-inhibiittoreita | |
| AU2001246477A1 (en) | Farnesyl protein transferase inhibitor combinations with platinum compounds | |
| ATE359281T1 (de) | Tricyclic antitumor komponenten als farnesyl protein transferase inhibitoren | |
| ATE273299T1 (de) | Benzpyrido cycloheptan derivate mit farnesyl protein transferase inhibierender wirkung | |
| NO20012961D0 (no) | Trisykliske farnesylproteintransferase-inhibitorer | |
| DK1339695T3 (da) | Farnesyltransferase-inhibitorer | |
| EE200200206A (et) | Farnesüüli transferaasiinhibiitorid | |
| DE69711081D1 (de) | Farnesyl transferase inhibitoren | |
| AU3514302A (en) | 0ovel farnesyl protein transferase inhibitors | |
| ATE323096T1 (de) | Prenyltransferase-inhibitoren | |
| NO20022923D0 (no) | Inhibitorer av farnesyl-protein-transferase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |